Recap: BioXcel Therapeutics Q3 Earnings

BioXcel Therapeutics BTAI reported its Q3 earnings results on Tuesday, November 14, 2023 at 07:00 AM.

Here's what investors need to know about the announcement.

BioXcel Therapeutics missed estimated earnings by 20.61%, reporting an EPS of $-1.58 versus an estimate of $-1.31.

Revenue was up $204 thousand from the same period last year.

Last quarter the company missed on EPS by $0.08 which was followed by a 4.39% drop in the share price the next day.

Here's a look at BioXcel Therapeutics's past performance:

Quarter	Q2 2023	Q1 2023	Q4 2022	Q3 2022
EPS Estimate	-1.75	-1.62	-1.45	-1.35
EPS Actual	-1.83	-1.84	-1.95	-1.49
Revenue Estimate	450K	500K	1.25M	1.09M
Revenue Actual	457K	206K	238K	137K

To track all earnings releases for BioXcel Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Calendar